Development of a Melting-Curve-Based Multiplex Real-Time PCR Assay for the Simultaneous Detection of Viruses Causing Respiratory Infection
Authors:
- Eliandro Reis TavaresETEliandro Reis Tavares
- Thiago Ferreira de LimaTLThiago Ferreira de Lima
- Guilherme Bartolomeu-GonçalvesGBGuilherme Bartolomeu-Gonçalves
- Isabela Madeira de CastroICIsabela Madeira de Castro
- Daniel Gaiotto de LimaDLDaniel Gaiotto de Lima
- Paulo Henrique Guilherme BorgesPBPaulo Henrique Guilherme Borges
- Gerson NakazatoGNGerson Nakazato
- Renata Katsuko Takayama KobayashiRKRenata Katsuko Takayama Kobayashi
- Emerson José VenancioEVEmerson José Venancio
- César Ricardo Teixeira TarleyCésar Ricardo Teixeira Tarley
- Elaine Regina Delicato de AlmeidaEAElaine Regina Delicato de Almeida
- Marsileni PelissonMPMarsileni Pelisson
Open Access
- 2 November 2023
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 11 (11) , 2692
Abstract
The prompt and accurate identification of the etiological agents of viral respiratory infections is a critical measure in mitigating outbreaks. In this study, we developed and clinically evaluated a novel melting-curve-based multiplex real-time PCR (M-m-qPCR) assay targeting the RNA-dependent RNA polymerase (RdRp) and nucleocapsid phosphoprotein N of SARS-CoV-2, the Matrix protein 2 of the Influenza A virus, the RdRp domain of the L protein from the Human Respiratory Syncytial Virus, and the polyprotein from Rhinovirus B genes. The analytical performance of the M-m-qPCR underwent assessment using in silico analysis and a panel of reference and clinical strains, encompassing viral, bacterial, and fungal pathogens, exhibiting 100% specificity. Moreover, the assay showed a detection limit of 10 copies per reaction for all targeted pathogens using the positive controls. To validate its applicability, the assay was further tested in simulated nasal fluid spiked with the viruses mentioned above, followed by validation on nasopharyngeal swabs collected from 811 individuals. Among them, 13.4% (109/811) tested positive for SARS-CoV-2, and 1.1% (9/811) tested positive for Influenza A. Notably, these results showed 100% concordance with those obtained using a commercial kit. Therefore, the M-m-qPCR exhibits great potential for the routine screening of these respiratory viral pathogens.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (402387/2020-1, 01, 219/2023 PDI)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (402387/2020-1, 01, 219/2023 PDI)
- Fundação Araucária (402387/2020-1, 01, 219/2023 PDI)
This publication has 50 references indexed in Scilit:
- Influenza A Virus M2 Protein: Roles from Ingress to EgressInternational Journal of Molecular Sciences, 2017
- Direct-acting antivirals and host-targeting strategies to combat enterovirus infectionsCurrent Opinion in Virology, 2017
- Accurate and sensitive real-time PCR assays using intergenic spacer 1 region to differentiateCryptococcus gattii sensu latoandCryptococcus neoformans sensu latoMedical Mycology, 2015
- DIFFERENTIAL DIAGNOSIS OF RESPIRATORY VIRUSES BY USING REAL TIME RT-PCR METHODOLOGYRevista do Instituto de Medicina Tropical de São Paulo, 2013
- Point-Counterpoint: Is the Era of Viral Culture Over in the Clinical Microbiology Laboratory?Journal of Clinical Microbiology, 2013
- Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and EvolutionScience, 2009
- Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactionsJournal of Clinical Virology, 2005
- Influenza: historical aspects of epidemics and pandemicsInfectious Disease Clinics of North America, 2004
- The road to RNase PNature Structural & Molecular Biology, 2000
- A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12American Journal of Epidemiology, 1938